New Oral COVID-19 Antiviral Might Be Better Than Pfizer’s Paxlovid With Faster Recovery, Fewer Side Effects, Data Shows – Pfizer (NYSE:PFE)
[ad_1] by Vandana Singh, Benzinga Editor December 30, 2022 7:39 AM | 1 min read A study in China shows that a remdesivir analog, dubbed VV116, is as effective…
US Customs Stops Imports From Three Companies Assuming Use of Forced Labor – iShares China Large-Cap ETF (ARCA:FXI), Global X MSCI China Financials ETF (ARCA:CHIX)
[ad_1] U.S. Customs and Border Protection has detained imports from North Korean companies after indications that these used forced labor. The companies included – Zhejiang Sunrise Garment Group…
Have A Look At William Blair’s Top Biotech Picks For 2023 – Neurocrine Biosciences (NASDAQ:NBIX)
[ad_1] William Blair & Company’s report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period. Seagen Inc.’s SGEN Padcev could potentially…
Winter Storm Elliott Continues To Unleash Havoc With 24 Dead, Several Thousand Homes Without Power During The Holidays
[ad_1] Strong winds and subzero temperatures are causing chaos across the U.S. with millions without power and thousands stranded during Christmas. The weather system intensified Friday into a bomb cyclone. The…
Twitter Reinstates Its Suicide Prevention Feature After Public Outcry
[ad_1] Twitter restored a feature that promoted suicide prevention hotlines and support groups after its CEO Elon Musk faced criticism over the removal. What Happened: On Friday, Reuters reported the social media…